Solid Biosciences Inc at BMO Capital Markets BioPharma Spotlight Series: Genetic Medicine Delivery (Virtual) Transcript
Good morning. My name is Bert Powell, and I'm the Global Director of Research here at BMO Capital Markets. So it's my pleasure to welcome you to today's Biopharma Spotlight Series on novel technologies for the delivery of genetic medicines.
It's an important new class of medicines that are the emerging technology in life sciences today. BMO Capital Markets biotech research analyst Kostas Biliouris will moderate all 4 of today's panel discussions. Each panel will take a deep dive with the companies who are leading the research and the development genetic medicines through adeno-associated viruses, where in a naturally occurring virus is converted into a delivery mechanism for genetic medicines, lipid nanoparticles were nanoparticles comprised of lipids and were used in COVID vaccines and other delivery platforms that can potentially address some of the limitations in adeno-associated viruses and lipid nanoparticles.
Our last panel today will focus on the drug delivery in the CNS space, and we look
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
